Senti Biosciences Holdings, Inc. (SNTI)
Nasdaq: SNTI · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2021
Who owns Senti Biosciences Holdings, Inc.
As filed with the SECHolders of 5% or more
4
Celadon Partners SPV 24 holds 54.6% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13D/A filed Sep 11, 2026 says.
Directors and officers
2
report now, of 23 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Celadon Partners SPV 24
SCHEDULE 13D/A · filed Sep 11, 2026 · Common Stock, par value $0.0001 per share · 54.6% in Jul 16, 2026
Bayer HealthCare LLC
SCHEDULE 13D/A · filed Apr 16, 2026 · Common Stock, par value $0.0001 per share · 20% in Mar 17, 2025
New Enterprise Associates 15, L.P.
SCHEDULE 13D/A · filed Mar 31, 2026 · Common Stock, $0.0001 par value · 14.5% in Mar 10, 2025
Nantahala Capital Management, LLC
SCHEDULE 13G/A · filed May 15, 2025 · Common stock, par value $0.0001 per share · 8.12% in May 15, 2025
Armistice Capital, LLC
SCHEDULE 13G/A · filed May 15, 2025 · Class A Common Stock, par value $0.0001 per share · reported falling below 5%, from 9.99% in Feb 14, 2025
Nantahala Capital Partners Limited Partnership
SCHEDULE 13G/A · filed May 15, 2025 · Common stock, par value $0.0001 per share · reported falling below 5%, from 5.91% in Feb 14, 2025
8VC Fund I, L.P.
SCHEDULE 13G/A · filed May 7, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%
What SNTI reports owning in othersstakes of 5% or more, and other ties
Senti Biosciences Holdings, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 23, 2025 to Oct 23, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
2025 runs to Oct 23, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.